Peter H Dube
Overview
Explore the profile of Peter H Dube including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
1091
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wiscovitch-Russo R, Ibanez-Prada E, Serrano-Mayorga C, Sievers B, Engelbride M, Padmanabhan S, et al.
Crit Care
. 2023 Apr;
27(1):155.
PMID: 37081485
Background: The mechanisms used by SARS-CoV-2 to induce major adverse cardiac events (MACE) are unknown. Thus, we aimed to determine if SARS-CoV-2 can induce necrotic cell death to promote MACE...
2.
Wiscovitch-Russo R, Ibanez-Prada E, Serrano-Mayorga C, Sievers B, Engelbride M, Padmanabhan S, et al.
Res Sq
. 2023 Jan;
PMID: 36711834
Background The mechanisms used by SARS-CoV-2 to induce major adverse cardiac events (MACE) are unknown. Thus, we aimed to determine if SARS-CoV-2 can infect the heart to kill cardiomyocytes and...
3.
Ma H, Zhang X, Zheng P, Dube P, Zeng W, Chen S, et al.
Cell Res
. 2022 Jul;
32(9):831-842.
PMID: 35906408
SARS-CoV-2 variants with adaptive mutations have continued to emerge, causing fresh waves of infection even amongst vaccinated population. The development of broad-spectrum antivirals is thus urgently needed. We previously developed...
4.
Cantwell A, Singh H, Platt M, Yu Y, Lin Y, Ikeno Y, et al.
J Virol
. 2021 Jul;
95(20):e0101021.
PMID: 34319784
The host response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is poorly understood due to a lack of an animal model that recapitulates severe human disease. Here, we report...
5.
Lin Y, Platt M, Gilley R, Brown D, Dube P, Yu Y, et al.
Circ Res
. 2021 Jan;
128(5):570-584.
PMID: 33501852
Rationale: Patients with and without cardiovascular diseases have been shown to be at risk of influenza-mediated cardiac complications. Recent clinical reports support the notion of a direct link between laboratory-confirmed...
6.
She L, Barrera G, Yan L, Alanazi H, Brooks E, Dube P, et al.
JCI Insight
. 2021 Jan;
6(3).
PMID: 33400692
2'3'-cGAMP is known as a nonclassical second messenger and small immune modulator that possesses potent antitumor and antiviral activities via inducing the stimulator of IFN genes-mediated (STING-mediated) signaling pathway. However,...
7.
Gonzalez-Juarbe N, Riegler A, Jureka A, Gilley R, Brand J, Trombley J, et al.
Cell Rep
. 2020 Aug;
32(8):108062.
PMID: 32846120
Pneumonias caused by influenza A virus (IAV) co- and secondary bacterial infections are characterized by their severity and high mortality rate. Previously, we have shown that bacterial pore-forming toxin (PFT)-mediated...
8.
She L, Alanazi H, Yan L, Brooks E, Dube P, Xiang Y, et al.
PLoS One
. 2020 Jul;
15(7):e0236744.
PMID: 32730309
Repeated exposures to environmental allergens in susceptible individuals drive the development of type 2 inflammatory conditions such as asthma, which have been traditionally considered to be mainly mediated by Th2...
9.
Gilley R, Dube P
Am J Public Health
. 2020 Jul;
110(8):1143-1144.
PMID: 32639917
No abstract available.
10.
Gilley R, Dube P
Oncotarget
. 2020 Mar;
11(7):740-754.
PMID: 32133048
Melanoma continues to be a significant health concern worldwide despite recent improvements in treatment. Unlike many other prominent cancers, melanoma incidence in both men and women increased over the past...